Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,058 public trials 2,038 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Clinical Trial of PXD101 in Patients With Advanced Multiple Myeloma

NCT00131261

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • James Berenson, MD, Inc West Hollywood, California, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern University Chicago, Illinois, United States
  • Research Facility New York, United States
View Trial Details
Completed

A Study of APO866 for the Treatment of Cutaneous T-cell Lymphoma

NCT00431912

Conditions
Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Department of Dermatology, Medical University Graz Graz, Austria
  • Deapartment of Dermatology Créteil, France
  • department of Dermatologie, Hotel Dieu Nantes, France
  • University Clinic for Dermatology, Medical Faculty of Mannheim of the Heidelberg University Mannheim, Germany
View Trial Details
Completed

Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery

NCT00608361

Conditions
Adenocarcinoma, Adult Acute Lymphoblastic Leukemia in Remission, Adult B Acute Lymphoblastic Leukemia, +144 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Los Angeles County-USC Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 23 locations
View Trial Details
Completed

A Phase II Study of MGCD0103 (MG-0103) in Patients With Refractory Chronic Lymphocytic Leukemia

NCT00431873

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +24 more
Locations
  • Veteran Affairs Medical Center Research Service Kansas City, Missouri, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Gabrail Cancer Center Canton, Ohio, United States
  • Cleveland Clinic/Chronic Leukemia/Multiple Myeloma Program Cleveland, Ohio, United States
View all 13 locations
View Trial Details
Completed

Study of MGCD0103 Given Three Times Weekly in Patients With Relapsed and Refractory Lymphoma

NCT00359086

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Duke University Adult Bone Marrow Transplant Clinic Durham, North Carolina, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Ottawa Hospital - General Campus Ottawa, Ontario, Canada
  • Charles LeMoyne Hospital Greenfield Park, Quebec, Canada
View Trial Details
Completed

A Phase 1 Safety Study of LY2127399 in Combination With Bortezomib

NCT00689507

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • UCLA Los Angeles, California, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions